Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BIO-PATH HOLDINGS, INC.BPTH · Entity 9692 | Director | March 23, 2017 | March 27, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BIO-PATH HOLDINGS, INC.
Report date March 23, 2017 · Filed March 27, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.80 · Expires 2027-03-23 | Direct | 25,000 |
Reported balance
After 2017-03-23 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-03-23 · Grant · Acquired 25,000 · Balance 25,000 F1: This option vests over a four-year period, with one-fourth (1/4) of the 25,000 shares vesting on the first anniversary of March 23, 2017 and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 25,000 shares, based on continuing service to Bio-Path Holdings, Inc. |
Filing footnotes · ownership attribution and instrument terms
F1: This option vests over a four-year period, with one-fourth (1/4) of the 25,000 shares vesting on the first anniversary of March 23, 2017 and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 25,000 shares, based on continuing service to Bio-Path Holdings, Inc.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 23, 2017 Filed Mar 27, 2017 20:21 UTC | BIO-PATH HOLDINGS, INC. BPTH · Entity 9692 | GrantCommon Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001007382-17-000002 · primary_doc.xml · derivative · entry 1 SING AMY · CIK 0001202789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-03-23 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 25,000 shares vesting on the first anniversary of March 23, 2017 and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 25,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.